acetazolamide has been researched along with Cerebellar Diseases in 9 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Cerebellar Diseases: Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This syndrome is 1 of the few treatable causes of chronic episodic vertigo." | 5.28 | Acetazolamide-responsive vestibulocerebellar syndrome: clinical and oculographic features. ( Baloh, RW; Winder, A, 1991) |
| " AZATAX was designed to establish whether acetazolamide is safe and improves cerebellar syndrome in PMM2-CDG." | 2.90 | AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG). ( Arango, P; Artuch, R; Bolasell, M; Callejón-Póo, L; Casas-Alba, D; Corral, J; Cuadras, D; de la Morena, E; Freniche, V; Gassiot, S; Itzep, DC; Jaeken, J; Martínez-Monseny, AF; Montero, R; Pérez, B; Pérez-Cerdá, C; Serrano, M, 2019) |
| "In 53 patients with chronic occlusive cerebrovascular diseases, we evaluated cerebral perfusion reserve." | 2.68 | [SPECT evaluation of cerebral perfusion reserve in patients with occlusive cerebrovascular diseases: evaluation with acetazolamide test and crossed cerebellar diaschisis]. ( Sugawara, Y, 1995) |
| "This syndrome is 1 of the few treatable causes of chronic episodic vertigo." | 1.28 | Acetazolamide-responsive vestibulocerebellar syndrome: clinical and oculographic features. ( Baloh, RW; Winder, A, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martínez-Monseny, AF | 1 |
| Bolasell, M | 1 |
| Callejón-Póo, L | 1 |
| Cuadras, D | 1 |
| Freniche, V | 1 |
| Itzep, DC | 1 |
| Gassiot, S | 1 |
| Arango, P | 1 |
| Casas-Alba, D | 1 |
| de la Morena, E | 1 |
| Corral, J | 1 |
| Montero, R | 1 |
| Pérez-Cerdá, C | 1 |
| Pérez, B | 1 |
| Artuch, R | 1 |
| Jaeken, J | 1 |
| Serrano, M | 1 |
| Atmakuri, M | 1 |
| Garritano, FG | 1 |
| Kanekar, SG | 1 |
| Ghossaini, SN | 1 |
| Dudeck, O | 1 |
| van Velthoven, V | 1 |
| Schumacher, M | 1 |
| Klisch, J | 1 |
| Sugawara, Y | 1 |
| Terada, H | 1 |
| Gomi, T | 1 |
| Sasaki, K | 1 |
| Murakami, S | 1 |
| Sato, S | 1 |
| Nagamoto, M | 1 |
| Kuwajima, A | 1 |
| Hiramatsu, Y | 1 |
| Iwabuchi, S | 1 |
| Samejima, H | 1 |
| Chalaupka, FD | 1 |
| Matsuda, H | 1 |
| Tsuji, S | 1 |
| Sumiya, H | 1 |
| Hogashi, S | 1 |
| Kinuya, K | 1 |
| Tonami, N | 1 |
| Hisada, K | 1 |
| Yamashita, J | 1 |
| Baloh, RW | 1 |
| Winder, A | 1 |
| Bogsrud, TV | 1 |
| Rootwelt, K | 1 |
| Russell, D | 1 |
| Nyberg-Hansen, R | 1 |
2 reviews available for acetazolamide and Cerebellar Diseases
| Article | Year |
|---|---|
Radiology quiz case 1: suspected arachnoid cyst of the right cerebellopontineangle.
Topics: Acetazolamide; Arachnoid Cysts; Cerebellar Diseases; Cerebellopontine Angle; Contrast Media; Female; | 2013 |
Development of a complex dural arteriovenous fistula next to a cerebellar developmental venous anomaly after resection of a brainstem cavernoma. Case report and review of the literature.
Topics: Acetazolamide; Adolescent; Brain Stem Neoplasms; Central Nervous System Vascular Malformations; Cere | 2004 |
2 trials available for acetazolamide and Cerebellar Diseases
| Article | Year |
|---|---|
AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
Topics: Acetazolamide; Adolescent; Carbonic Anhydrase Inhibitors; Cerebellar Diseases; Child; Child, Prescho | 2019 |
[SPECT evaluation of cerebral perfusion reserve in patients with occlusive cerebrovascular diseases: evaluation with acetazolamide test and crossed cerebellar diaschisis].
Topics: Acetazolamide; Adult; Aged; Brain; Cerebellar Diseases; Cerebrovascular Circulation; Cerebrovascular | 1995 |
5 other studies available for acetazolamide and Cerebellar Diseases
| Article | Year |
|---|---|
[Acetazolamide effect on vascular response in crossed cerebellar diaschisis as measured by 99mTc-HMPAO SPECT].
Topics: Acetazolamide; Adult; Cerebellar Diseases; Cerebrovascular Circulation; Female; Humans; Male; Organo | 1993 |
Therapeutic effectiveness of acetazolamide in hindbrain hernia headache.
Topics: Acetazolamide; Adult; Cerebellar Diseases; Decompression, Surgical; Encephalocele; Headache; Humans; | 2000 |
Acetazolamide effect on vascular response in areas with diaschisis as measured by Tc-99m HMPAO brain SPECT.
Topics: Acetazolamide; Adult; Aged; Cerebellar Diseases; Cerebrovascular Disorders; Female; Humans; Male; Mi | 1992 |
Acetazolamide-responsive vestibulocerebellar syndrome: clinical and oculographic features.
Topics: Acetazolamide; Adult; Cerebellar Diseases; Eye; Humans; Middle Aged; Nervous System; Oculomotor Musc | 1991 |
Acetazolamide effect on cerebellar blood flow in crossed cerebral-cerebellar diaschisis.
Topics: Acetazolamide; Adult; Aged; Brain Diseases; Cerebellar Diseases; Cerebellum; Cerebral Arteries; Fema | 1990 |